CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Transchem Ltd

Transchem Ltd

BSE 500422 TRANSCHEM INE019B01010
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

17 filings · 4 material · busiest 2026-08-10

What it files

General2 SAST2 Contract / MoU1 Acquisition1 Newspaper Publication1 Board Outcome1 Results1 Monitoring Agency1

Filings

17 in the window

  1. 17 August 2026

    Contract / MoU

    Memorandum of Understanding /Agreements

    Please refer the attached intimation.

    Company Update / Memorandum of Understanding /Agreements View filing →

  2. 17 August 2026

    Acquisition

    Updates on Acquisition

    Please refer the attached intimation.

    Company Update / Acquisition View filing →

  3. 12 August 2026

    Newspaper Publication

    Newspaper Publication

    Please refer the attached intimation.

    Company Update / Newspaper Publication View filing →

  4. 10 August 2026

    Board Outcome

    Board Meeting Outcome for The Meeting Held On August 10, 2026, Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please refer the attached intimation.

    Board Meeting / Outcome of Board Meeting View filing →

  5. 10 August 2026

    Results

    Un-Audited Financial Results For The Quarter Ended June 30, 2026

    Please refer the attached intimation.

    Result / Financial Results View filing →

  6. 10 August 2026

    General

    Amendment To The Code Of Conduct For Prevention Of Insider Trading

    Please refer the attached intimation.

    Company Update / General View filing →

  7. 10 August 2026

    Monitoring Agency

    Monitoring Agency Report

    Please refer the attached Monitoring Agency Report for the quarter ended June 30, 2026.

    Company Update / Monitoring Agency Report View filing →

  8. 3 August 2026

    Board Meeting

    Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended June 30, 2026

    Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....

    Board Meeting / Board Meeting View filing →

  9. 31 July 2026

    AGM / EGM

    500422 - Notice Of The 49Th Annual General Meeting Of The Members Of The Company And Annual Report For The Financial Year 2025-26

    Please refer the attached intimation.

    AGM/EGM / AGM View filing →

  10. 31 July 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Please refer the attached intimation.

    Others / Reg. 34 (1) Annual Report View filing →

  11. 31 July 2026

    General

    500422 - Letter To Members Pursuant To Regulation 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please refer the attached intimation.

    Company Update / General View filing →

  12. 8 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please refer the attached intimation.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  13. 25 June 2026

    Trading Window

    Closure of Trading Window

    Please refer the attached intimation.

    Insider Trading / SAST / Closure of Trading Window View filing →

  14. 5 June 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pishu V Chainani

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  15. 5 June 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bakkt Opco Holdings, LLC

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  16. 3 June 2026

    Outcome

    Board Meeting Outcome for Preferential Issue Committee Meeting Held On June 03, 2026

    Please refer the attached intimation.

    Others / Outcome without intimation View filing →

  17. 3 June 2026

    Allotment

    Allotment

    Please refer the attached intimation.

    Company Update / Allotment of Equity Shares View filing →